Search

Your search keyword '"Verhoef S"' showing total 311 results

Search Constraints

Start Over You searched for: Author "Verhoef S" Remove constraint Author: "Verhoef S"
311 results on '"Verhoef S"'

Search Results

3. Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.

4. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

14. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

15. Duodenal carcinoma in MUTYH-associated polyposis

24. Tuberous sclerosis complex

25. Tubereuze-Sclerosecomplex

28. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP)

32. PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS

33. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

35. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

36. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

38. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

39. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

40. Refined histopathological predictors of BRCA1\ud and BRCA2 mutation status: a large-scale analysis\ud of breast cancer characteristics from the BCAC,\ud CIMBA, and ENIGMA consortia

41. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

42. BRCA1/2 mutation carriers do not have earlier natural menopause compared to proven non-carriers: report from the Dutch hereditary breast and ovarian cancer study group (HEBON)

43. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

44. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

45. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

46. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

47. Genome-wide association analysis identifies three new breast cancer susceptibility loci

48. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

49. Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

50. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

Catalog

Books, media, physical & digital resources